glp-1 and cancer risk Long-term in users of agonists in Denmark: a nationwide emulated trial An important article from @americancancersociety
Description
Lean on: a steady, moderate amount of fiber
I know, weight loss is the whole point of some GLP-1s
These drugs, acting as agonists of Glucagon-like Peptide-1 receptor (GLP-1R), are recognized for promoting insulin secretion, suppressing glucagon release, and delaying gastric emptying [1]
Skofitsch, G., Wimalawansa, S
Abbreviations: DMT2, diabetes mellitus type 2
Therefore, the aim of this study was to examine the analgesic and anti-inflammatory properties of liraglutide in treating OA, using in vivo and in vitro experiments
